0001493152-23-029825.txt : 20230822 0001493152-23-029825.hdr.sgml : 20230822 20230822161018 ACCESSION NUMBER: 0001493152-23-029825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230818 FILED AS OF DATE: 20230822 DATE AS OF CHANGE: 20230822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carey Robert CENTRAL INDEX KEY: 0001602064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38892 FILM NUMBER: 231193565 MAIL ADDRESS: STREET 1: HORIZON PHARMA, INC. STREET 2: 520 LAKE COOK ROAD, SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beyond Air, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 900 STEWART AVENUE STREET 2: SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 BUSINESS PHONE: 516-665-8200 MAIL ADDRESS: STREET 1: 900 STEWART AVENUE STREET 2: SUITE 301 CITY: GARDEN CITY STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: AIT Therapeutics, Inc. DATE OF NAME CHANGE: 20170117 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 4 1 ownership.xml X0508 4 2023-08-18 0 0001641631 Beyond Air, Inc. XAIR 0001602064 Carey Robert C/O BEYOND AIR, INC. 900 STEWART AVENUE, SUITE 301 GARDEN CITY NY 11530 1 0 0 0 0 Common Stock 2023-08-18 4 P 0 13614 2.6399 A 900110 D Common Stock 2023-08-21 4 P 0 75050 2.7642 A 975160 D This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.635 to $2.64, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.655 to $2.78, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. /s/ Robert Carey 2023-08-22